Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin B Freeman

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Comparative Medicine|January 31, 2019
Ketamine Tolerance in Sprague-Dawley Rats after Chronic Administration of Ketamine, Morphine, or CocaineSamantha A Gerb, Jemma E Cook, Alexandria E Gochenauer, et al.
Psychopharmacology|October 23, 2023
Contingent administration of typical and biased kappa opioid agonists reduces cocaine and oxycodone choice in a drug vs. food choice procedure in male rhesus monkeysC Austin Zamarripa, Sally L Huskinson, E Andrew Townsend, et al.
Human Brain Mapping|February 23, 2018
A comparison of manual tracing and FreeSurfer for estimating hippocampal volume over the adult lifespanMike F Schmidt, Judd M Storrs, Kevin B Freeman, et al.
Journal of the American Geriatrics Society|August 24, 2016
Associations Between Serum Inflammatory Markers and Hippocampal Volume in a Community SampleMike F Schmidt, Kevin B Freeman, Beverly G Windham, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 7, 2025
Using a rich-lean transition procedure to evaluate putative antianxiety medicationsForrest Toegel, Cory Toegel, James K Rowlett, et al.
Pharmacology, Biochemistry, and Behavior|May 5, 2022
The G-protein biased kappa opioid agonists, triazole 1.1 and nalfurafine, produce non-uniform behavioral effects in male rhesus monkeysSally L Huskinson, Donna M Platt, C Austin Zamarripa, et al.
Psychopharmacology|September 27, 2024
Comparison of the reinforcing, antinociceptive, and respiratory depressant effects of prototypical and G-protein biased mu-opioid receptor agonists in male and female Sprague-Dawley ratsC Austin Zamarripa, Tanya Pareek, Loc M Pham, et al.
Drug and Alcohol Dependence|September 21, 2023
Quantification of observable behaviors following oral administration of oxycodone and nalfurafine in male rhesus monkeysSally L Huskinson, Donna M Platt, Zachary R Smith, et al.
Translational Psychiatry|April 17, 2026
Cross-Species evidence for hippocampal CACNA1C as a therapeutic target for alcohol use disorderTanya Pareek, Loc M Pham, Sinead M O'Donovan, et al.
Neuropharmacology|May 16, 2024
Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pK<sub>a</sub> fluorinated fentanyl analogs, FF3 and NFEPPShelley R Edwards, Bruce E Blough, Kristian Cowart, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Comparative Medicine|January 31, 2019
Ketamine Tolerance in Sprague-Dawley Rats after Chronic Administration of Ketamine, Morphine, or CocaineSamantha A Gerb, Jemma E Cook, Alexandria E Gochenauer, et al.
Psychopharmacology|October 23, 2023
Contingent administration of typical and biased kappa opioid agonists reduces cocaine and oxycodone choice in a drug vs. food choice procedure in male rhesus monkeysC Austin Zamarripa, Sally L Huskinson, E Andrew Townsend, et al.
Human Brain Mapping|February 23, 2018
A comparison of manual tracing and FreeSurfer for estimating hippocampal volume over the adult lifespanMike F Schmidt, Judd M Storrs, Kevin B Freeman, et al.
Journal of the American Geriatrics Society|August 24, 2016
Associations Between Serum Inflammatory Markers and Hippocampal Volume in a Community SampleMike F Schmidt, Kevin B Freeman, Beverly G Windham, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 7, 2025
Using a rich-lean transition procedure to evaluate putative antianxiety medicationsForrest Toegel, Cory Toegel, James K Rowlett, et al.
Pharmacology, Biochemistry, and Behavior|May 5, 2022
The G-protein biased kappa opioid agonists, triazole 1.1 and nalfurafine, produce non-uniform behavioral effects in male rhesus monkeysSally L Huskinson, Donna M Platt, C Austin Zamarripa, et al.
Psychopharmacology|September 27, 2024
Comparison of the reinforcing, antinociceptive, and respiratory depressant effects of prototypical and G-protein biased mu-opioid receptor agonists in male and female Sprague-Dawley ratsC Austin Zamarripa, Tanya Pareek, Loc M Pham, et al.
Drug and Alcohol Dependence|September 21, 2023
Quantification of observable behaviors following oral administration of oxycodone and nalfurafine in male rhesus monkeysSally L Huskinson, Donna M Platt, Zachary R Smith, et al.
Translational Psychiatry|April 17, 2026
Cross-Species evidence for hippocampal CACNA1C as a therapeutic target for alcohol use disorderTanya Pareek, Loc M Pham, Sinead M O'Donovan, et al.
Neuropharmacology|May 16, 2024
Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pK<sub>a</sub> fluorinated fentanyl analogs, FF3 and NFEPPShelley R Edwards, Bruce E Blough, Kristian Cowart, et al.
Pageof 6